15
Participants
Start Date
September 30, 2009
Primary Completion Date
May 31, 2012
Study Completion Date
August 31, 2017
Sorafenib & Capecitabine
Intervention: Sorafenib twice a day by mouth (400mg), Capecitabine twice a day by mouth (850mg). One cycle of treatment will consist of capecitabine on days 1-7 and 15-22 while sorafenib will be given daily continuously. Cycles will be repeated every 28 days.
University of New Mexico Cancer Center @ Lovelace Medical Center, Albuquerque
University of New Mexico Cancer Center, Albuquerque
Cancer Center at Presbyterian Hospital, Albuquerque
Collaborators (1)
Bayer
INDUSTRY
New Mexico Cancer Research Alliance
OTHER